Atlas Trials

Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury

Clinical trial NCT02975271 · TERMINATED

Trial details

NCT number
NCT02975271
Sponsor
Vyne Therapeutics Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
PruritusBurns
Start date
2016-11-01
Primary completion
2017-01-17
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.